Compare multi-agent consensus ratings, forecast paths, AI price targets, expected return, fundamentals, analyst disagreement, risks, and the investment thesis across short- and long-term horizons.

DSY.PAR

Dassault Systemes

Technology | Software - Application

Industrial software company providing 3D design, PLM, and digital twin platforms for aerospace, manufacturing, and life sciences.

Flagship Insight

Why the Market Misunderstands the Physics Moat of Industrial Software

High consensus across reports indicates that the market is mispricing a monopolistic industrial software provider as a cyclical hardware vendor. While European stagflation presents near-term headwinds, structural tailwinds from global defense re-armament, supply chain reshoring, and deterministic physical simulation provide a robust long-term cash-flow floor.

Forecast TimelineUpdated On Jul 03 2026

Dassault Systemes (DSY) Stock Forecast and AI Rating

Recommendation

Small Buy

Open a small position; wait before adding more.

2027

1-Year

BUY

€21

+14.9%

+15.3% IF INCL. DIVS

2029

3-Year

N/A

€27

+51%

2031

5-Year

BUY

€33

+78%

+89% IF INCL. DIVS

LATEST DEEP FORECAST ANALYSIS BY iPULSE AI ENGINE | Jul 05, 2026

Visionary, Superintelligence, Insider, Strategist, Value Seeker, Vulture, Whistleblower, and more.

Elon Musk (Visionary), Superintelligence (Anthropologist), Machiavelli (Insider), Ray Dalio (Strategist), Warren Buffett (Value Purist), Michael Burry (Vulture), Sherlock Holmes (Whistleblower).

Research support only. We don't give financial advice.

Computed on these frontier AI models

Gemini

Claude

ChatGPT

Grok

Investment Thesis Takeaway

Expert LanguageExpert Quant Language

Explained Simply

Interactive forecast chart

Expert Language

Explained Simply

The overarching investment thesis centers on a classic time-arbitrage opportunity, where the market over-extrapolates cyclical European industrial headwinds and temporary subscription transition friction into a permanent structural decline. The core base-case narrative assumes a methodical, cash-flow-driven recovery as the business transitions from upfront transactional licenses to high-LTV recurring SaaS revenue. Over the five-year forecast horizon, the optical drag of this transition will fade, revealing a highly resilient, compounding annual recurring revenue base. Concurrently, the unavoidable global defense re-armament and aerospace supercycles will mandate deep reliance on the company's monopolistic 3D design and simulation platforms, structurally offsetting localized automotive weakness.

Key insights

Prohibitive enterprise switching costs secure an unassailable eighty-five percent recurring software revenue baseline.
Generational defense and aerospace capex supercycles provide a highly durable, inelastic demand floor.
The subscription transition J-curve temporarily masks underlying cash-generation velocity and ARR compounding.
A fortress balance sheet with zero net debt insulates the enterprise from restrictive credit regimes.
Strategic partnerships in physical AI and industrial world models unlock significant long-term pricing power.
Key risks include prolonged Eurozone stagflation and potential regulatory antitrust interventions in mid-market segments.
Practical implications suggest aggressive value accumulation during this period of temporary multiple compression.

Preparing your access...

AI Consensus

AI Opinions

Company Profile

Dassault Systemes quarterly forecast scenarios

One row per forecast quarter. Asset scenario targets are shown in EUR; benchmark values are shown in USD.

Quarterly Bear Case, Base Case, Bull Case, and S&P 500 benchmark forecasts for Dassault Systemes, including EUR/USD currency conversion forecasts.
Quarter	Forecast date	Bear Case (EUR)	Base Case (EUR)	Bull Case (EUR)	S&P 500 benchmark (USD)	Currency conversion forecast (EUR/USD)
Quarter 1+3M	Oct 03, 2026	€17.58	€18.98	€19.43	$736.09	1.1229
Quarter 2+6M	Jan 03, 2027	€16.87	€19.59	€20.98	$724.14	1.1119
Quarter 3+9M	Apr 03, 2027	€17.38	€20.19	€22.03	$713.57	1.1011
Quarter 4+1Y	Jul 03, 2027	€16.34	€20.55	€22.69	$723.38	1.1013
Quarter 5+15M	Oct 03, 2027	€15.85	€21.26	€24.05	$716.61	1.1013
Quarter 6+18M	Jan 03, 2028	€15.05	€22.10	€25.73	$738.34	1.1016
Quarter 7+21M	Apr 03, 2028	€15.66	€22.83	€26.76	$746.91	1.1058
Quarter 8+2Y	Jul 03, 2028	€15.97	€23.41	€28.10	$771.93	1.1079
Quarter 9+27M	Oct 03, 2028	€15.65	€24.07	€28.66	$782.73	1.1121
Quarter 10+30M	Jan 03, 2029	€16.12	€24.97	€30.38	$807.31	1.1138
Quarter 11+33M	Apr 03, 2029	€16.28	€25.73	€31.60	$822.72	1.1162
Quarter 12+3Y	Jul 03, 2029	€16.61	€26.54	€32.55	$846.10	1.1220
Quarter 13+39M	Oct 03, 2029	€16.44	€27.10	€34.17	$852.53	1.1263
Quarter 14+42M	Jan 03, 2030	€16.77	€28.06	€36.22	$882.91	1.1278
Quarter 15+45M	Apr 03, 2030	€16.94	€28.82	€37.31	$900.46	1.1296
Quarter 16+4Y	Jul 03, 2030	€17.27	€29.52	€38.80	$922.67	1.1291
Quarter 17+51M	Oct 03, 2030	€16.93	€30.28	€39.58	$935.91	1.1320
Quarter 18+54M	Jan 03, 2031	€17.10	€31.31	€41.56	$952.30	1.1343
Quarter 19+57M	Apr 03, 2031	€17.44	€32.10	€43.22	$976.28	1.1349
Quarter 20+5Y	Jul 03, 2031	€17.61	€32.99	€44.52	$1,002	1.1376

Alpha Gap and Advisor Disagreement

Alpha Gap

The core information gap lies in the market's fundamental mischaracterization of deterministic physical simulation versus probabilistic generative models. While the crowd panics over cyclical headwinds and temporary subscription transition friction, it overlooks the company's absolute monopoly on the proprietary physical and geometric datasets required to build automated factories, defense systems, and space infrastructure. The market prices the asset as a cyclical hardware derivative, ignoring its unassailable switching costs and eighty-four percent gross margins. The alpha gap is the massive disconnect between a priced-in permanent decline and the reality of a highly profitable, deeply entrenched digital infrastructure layer trading at a distressed free cash flow yield. This mispricing offers a highly asymmetric entry point into a sovereign-backed software monopoly.

Advisor Disagreement

The primary disagreement across the reports centers on the severity and duration of the European industrial slowdown versus the offset from defense and aerospace spending. While some assessments view the current revenue stagnation as a temporary, purely cyclical dip that offers a highly de-risked entry point, others adopt a more cautious stance, warning that structural deindustrialization in the Eurozone and market share losses at Medidata represent a permanent impairment of the core business model. Additionally, reports diverge on the execution velocity of the cloud transition and the near-term margin impact of heavy artificial intelligence research and development spending.

Financial Reviews by iPulse AI

Earnings and financials

The financial assessments agree that while recent sales growth has been slow—with revenue flat or slightly down due to weak European car and biotech markets—the actual quality of the company's earnings remains incredibly strong. The company generates massive amounts of cash, bringing in over one and a half billion euros in free cash flow annually. However, there is a clear disagreement on the future path. Optimistic views expect sales to speed up quickly as big defense and aerospace contracts start rolling in and the shift to subscription models pays off. Cautious views warn that the slowdown in European manufacturing and clinical trials is a deeper, long-term problem that will keep dragging down earnings. Overall, the company's ability to turn sales into pure cash provides a strong safety net while it navigates these mixed economic conditions.

Profitability and margins

The company boasts spectacular profitability, highlighted by gross margins of eighty-four percent and operating margins consistently above twenty-two percent. The assessments agree that these elite margins reflect immense pricing power and a highly loyal customer base that cannot easily switch to other software. However, there is a clear clash regarding the future margin outlook. Optimistic reports argue that as the transition to cloud subscriptions completes and new artificial intelligence tools are introduced, operating margins will expand toward thirty percent. Conversely, cautious reports suggest that margins are being artificially propped up by accounting adjustments and that high research costs, combined with intense competition in the mid-market and clinical trial segments, will keep margins under pressure. Despite these disagreements, the current margin profile remains far superior to most peers.

Balance sheet and leverage

The company's balance sheet is widely recognized as an absolute financial fortress, offering exceptional safety for investors. With over two billion euros in net cash, negligible debt, and massive interest coverage, the company is completely insulated from high interest rates and credit market stress. The assessments highly agree that this financial strength provides a powerful shield against economic downturns and gives management the unique ability to buy back its own shares at cheap prices or acquire smaller competitors. There is very little disagreement on this front, though some cautious reports note that the balance sheet's value is heavily tied to past acquisitions, which could face write-downs if underperforming divisions like clinical trial software do not recover. Nonetheless, the overall consensus is that the company's financial safety is top-tier.

Capex and investment intensity

The company operates a highly attractive, low-spending business model that requires very little physical investment, with capital expenditures taking up less than three percent of its revenue. Instead, the vast majority of its spending is directed toward research and development to build advanced artificial intelligence features and secure its competitive position. The assessments agree that this low-spending setup is a massive advantage in today's high-interest-rate environment, as the company can easily fund its own innovation without taking on expensive debt. However, opinions differ on the effectiveness of this heavy research spending. Some view it as a vital defensive shield that will unlock premium pricing power, while others worry it is a costly, defensive effort required just to keep up with faster, cloud-native competitors.